Peng T - Search Results

1

BORA regulates cell proliferation and migration in bladder cancer.

Cheng S, Peng T, Zhu X, Zhou F, Wang G, Ju L, Xiao Y, Liu X, Wang X. Cheng S, et al. Among authors: peng t. Cancer Cell Int. 2020 Jul 6;20:290. doi: 10.1186/s12935-020-01392-8. eCollection 2020. Cancer Cell Int. 2020. PMID: 32655322 Free PMC article.

2

Identification of several cell cycle relevant genes highly correlated with the progression and prognosis of human bladder urothelial tumor.

Wang L, Chen S, Luo Y, Yuan L, Peng T, Qian K, Liu X, Xiao Y, Wang X. Wang L, et al. Among authors: peng t. J Cell Physiol. 2019 Aug;234(8):13439-13451. doi: 10.1002/jcp.28023. Epub 2019 Jan 7. J Cell Physiol. 2019. PMID: 30618079

3

Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients.

Lu M, Chen S, Zhou Q, Wang L, Peng T, Wang G. Lu M, et al. Among authors: peng t. Medicine (Baltimore). 2019 Jul;98(28):e16426. doi: 10.1097/MD.0000000000016426. Medicine (Baltimore). 2019. PMID: 31305463 Free PMC article.

4

ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis.

Chen L, Peng T, Luo Y, Zhou F, Wang G, Qian K, Xiao Y, Wang X. Chen L, et al. Among authors: peng t. Front Oncol. 2019 Oct 9;9:957. doi: 10.3389/fonc.2019.00957. eCollection 2019. Front Oncol. 2019. PMID: 31649873 Free PMC article.

5

Establishing the prediction models for recurrence and progression of T1G3 bladder urothelial carcinoma.

Chen S, Lu M, Peng T, Wang Y, Liu X, Xiao Y, Wang X. Chen S, et al. Among authors: peng t. J Cancer. 2019 Oct 11;10(24):5891-5902. doi: 10.7150/jca.35866. eCollection 2019. J Cancer. 2019. PMID: 31762799 Free PMC article.

6

The role and function of PPARγ in bladder cancer.

Peng T, Wang G, Cheng S, Xiong Y, Cao R, Qian K, Ju L, Wang X, Xiao Y. Peng T, et al. J Cancer. 2020 Apr 6;11(13):3965-3975. doi: 10.7150/jca.42663. eCollection 2020. J Cancer. 2020. PMID: 32328200 Free PMC article. Review.

7

WFDC2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation.

Xiong Y, Yuan L, Chen S, Xu H, Peng T, Ju L, Wang G, Xiao Y, Wang X. Xiong Y, et al. Among authors: peng t. Cell Death Dis. 2020 Jul 16;11(7):537. doi: 10.1038/s41419-020-02752-y. Cell Death Dis. 2020. PMID: 32678075 Free PMC article.

8

TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells.

Wang G, Cao R, Qian K, Peng T, Yuan L, Chen L, Cheng S, Xiong Y, Ju L, Wang X, Xiao Y. Wang G, et al. Among authors: peng t. Onco Targets Ther. 2020 Sep 4;13:8825-8835. doi: 10.2147/OTT.S257056. eCollection 2020. Onco Targets Ther. 2020. PMID: 32943886 Free PMC article.

9

A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotype.

Qian K, Wang G, Ju L, Liu J, Luo Y, Wang Y, Peng T, Chen F, Zhang Y, Xiao Y, Wang X. Qian K, et al. Among authors: peng t. Oncogene. 2020 Oct;39(44):6871-6878. doi: 10.1038/s41388-020-01476-9. Epub 2020 Sep 25. Oncogene. 2020. PMID: 32978518

10

KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.

Xiong Y, Ju L, Yuan L, Chen L, Wang G, Xu H, Peng T, Luo Y, Xiao Y, Wang X. Xiong Y, et al. Among authors: peng t. Oncogene. 2021 Mar;40(9):1595-1608. doi: 10.1038/s41388-020-01634-z. Epub 2021 Jan 15. Oncogene. 2021. PMID: 33452459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,170 results

Search Page

Filters